Newsfeeds Archive - Page 3 of 5

1 minute read

Terns Pharmaceuticals To Highlight New Preclinical Data For TERN-601 Program In Obesity At The American Diabetes Association’s 83rd Annual Scientific Sessions

May 22, 4:13 PM

Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious

TERN

5 minute read

Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

May 16, 1:13 PM

Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering.

ADV

1 minute read

Analyst Ratings

Expert Ratings for Terns Pharma

By Benzinga Insights

May 8, 1:00 PM

Analysts have provided the following ratings for Terns Pharma (NASDAQ:TERN) within the last quarter: Bullish Somewhat Bullish Indifferent…

TERN

11 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For May 8, 2023

By Benzinga Insights

May 8, 11:00 AM

Upgrades Daiwa Capital upgraded the previous rating for Coinbase Global Inc (NASDAQ:COIN) from Hold to Buy. For the…

2 minute read

Analyst Ratings

The Latest Analyst Ratings for Terns Pharma

By Benzinga Insights

March 29, 9:00 AM

Within the last quarter, Terns Pharma (NASDAQ:TERN) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat…

TERN

3 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

March 28, 1:30 PM

Gainers Biomea Fusion (NASDAQ:BMEA) stock rose 76.2% to $27.19 during Tuesday’s regular session. Trading volume for Biomea Fusion’s…

BMEA

1 minute read

Why Terns Pharmaceuticals Shares Are Trading Higher Today

By Ye Kuang

March 28, 12:38 PM

Terns Pharmaceuticals (NASDAQ: TERN) shares are trading higher on Tuesday after the company reported Q4 financial results.

TERN

1 minute read

Reported Late Thursday, March 2, Terns Pharmaceuticals’ Program Updates; Q3 Adjusted Cash Balance As Of Sept 30, 2022, Of $293M Provides Cash Runway Into 2026

By Benzinga Newsdesk

March 3, 5:07 AM

Completes enrollment in Phase 2a DUET clinical trial of TERN-501 (THR-β agonist) as a treatment for NASH with top-line results expected in the third quarter of 2023 On track to initiate U.S. clinical trial

TERN

1 minute read

JMP Securities Initiates Coverage On Terns Pharma with Market Outperform Rating, Announces Price Target of $17

By Benzinga Newsdesk

February 14, 5:57 AM

JMP Securities analyst Silvan Tuerkcan initiates coverage on Terns Pharma (NASDAQ:TERN) with a Market Outperform rating and announces Price Target of $17.

TERN

1 minute read

CommVault Systems, Halozyme Therapeutics And Other Big Stocks Moving Lower On Wednesday

By Lisa Levin

January 11, 12:30 PM

U.S. stocks traded higher, with the Dow Jones gaining around 80 points on Wednesday. Here are some big stocks recording losses in today’s session.

CVAC